Clinical meaning
Travel medicine encompasses the prevention, assessment, and management of health risks associated with international travel, with primary focus on malaria prophylaxis, traveler's diarrhea, and travel-related vaccinations. Malaria is caused by Plasmodium parasites (P. falciparum, P. vivax, P. ovale, P. malariae, P. knowlesi) transmitted through the bite of female Anopheles mosquitoes. P. falciparum causes the most severe disease and is dominant in sub-Saharan Africa. The parasite undergoes a complex life cycle: sporozoites injected by the mosquito travel to hepatocytes (liver stage), mature into merozoites that infect red blood cells (erythrocytic stage), replicate within RBCs causing cyclical lysis (producing periodic fevers every 48 or 72 hours), and some develop into gametocytes that complete transmission back to mosquitoes. P. vivax and P. ovale form dormant hypnozoites in the liver that can reactivate months to years later, requiring primaquine or tafenoquine for radical cure (terminal prophylaxis). Traveler's diarrhea affects 30-70% of travelers to high-risk destinations (South Asia, Africa, Latin America), most commonly caused by enterotoxigenic E. coli (ETEC), followed by Campylobacter, Salmonella, and Shigella. It presents as ≥3 loose stools in 24 hours with cramps, nausea, and urgency. Severe complications include dehydration, reactive arthritis (Campylobacter, Salmonella, Shigella), and Guillain-Barre syndrome (Campylobacter). Prevention focuses on food and water precautions ('boil it, cook it, peel it, or forget it'), while treatment includes oral rehydration and antibiotics (azithromycin preferred for most destinations).